single nucleotide polymorphisms (sNps) in TLR genes may serve as a crucial marker for early susceptibility of various cancers including cervical cancer. the present study was therefore designed to ascertain the role of TLR4 and TLR9 sNps and haplotypes to hrHpV infection and cervical cancer susceptibility. The study included 110 cervical cancer biopsies and 141 cervical smears from age-matched healthy controls of Gujarati ethnicity of Western India. hrHPV 16 and 18 were detected using Realtime pCR. eight sNps, four each in TLR4 and TLR9 were analyzed using Polymerase Chain Reaction-Restriction Fragment Length Polymorphism and Allele-Specific PCR. HPV 16 and 18 were detected in 68% cervical cancer cases. TLR4 rs4986790, rs1927911 and TLR9 rs187084 showed association with HPV 16/18 infection. CC and CT genotypes of TLR4 rs11536889 and rs1927911 respectively, and TC, CC genotypes of TLR9 rs187084, as well as minor alleles of TLR4 rs4986790 and TLR9 rs187084, were associated with the increased risk of cervical cancer. Stage-wise analysis revealed TLR9 rs187084 and rs352140 to be associated with early-stage cancer. TLR4 haplotype GtAC and TLR9 haplotype GATC were associated with the increased risk of cervical cancer while TLR4 haplotype GCAG was associated with the decreased risk. TLR4 haplotype GCAG and TLR9 haplotype GAtC showed association with increased susceptibility to hrHpV infection. In conclusion, the present study revealed association of TLR4 and TLR9 polymorphisms and haplotypes with hrHpV infection and cervical cancer risk. Further evaluation of a larger sample size covering diverse ethnic populations globally is warranted. With respect to gender-specific cancers, cervical cancer is the next major cause of global cancer deaths among women, after the cancer of the breast, wherein India accounts for almost one-fourth of total cervical cancer-related mortalities 1. Human papillomavirus (HPV) infection is considered as the most vital event in the development and progression of cervical cancer, as the HPV DNA has been detected in almost all of the cervical tumors globally 2. With more than 200 HPV types known till date,

The Bishop score was superior in predicting the response to induction as compared to the cervical length measured by transvaginal ultrasonography.

Background Cervicitis is one of the major health problems amongst women caused by infection of various pathogens including Chlamydia trachomatis (CT), Neisseria gonorrhoeae (NG), Trichomonas vaginalis (TV) as well as human papillomavirus (HPV), and persistent cervical inflammation is one of the etiologic agents of cervical cancer. Toll-like receptors (TLRs) play an important role in the recognition and subsequent elimination of these pathogens. Variations in the Toll-like receptor genes influence susceptibility to pathogens as well as disease progression independently. Methods Ten single nucleotide polymorphisms, five each of TLR4 and TLR9 genes were analyzed among 130 cervicitis patients and 150 controls either using polymerase chain reaction-restriction fragment length polymorphism or allele specific-PCR. Results T . vaginalis infection was found at the highest frequency (30.7%) as compared to C . trachomatis (1.5%), N . gonorrhoeae (2.3%) and HPV (4.6%) infections in cervicitis patients. TLR4 rs11536889 CC (age-adjusted OR, 2.469 [95% CI, 1.499 to 4.065]; p < 0.001) and TLR9 rs187084 TC (age-adjusted OR, 2.165 [95% CI, 1.267–3.699]; p = 0.005) genotypes showed the higher distribution in cervicitis patients compared to controls. In addition, TLR4 rs11536889 C allele was shown to increase the risk of cervicitis (age-adjusted OR, 1.632 [95% CI, 1.132 to 2.352]; p = 0.009) compared to controls. The TLR4 haplotype GCA (OR, 0.6 [95% CI, 0.38–0.95]; p = 0.0272) and TLR9 haplotype GTA (OR, 1.99 [95% CI, 1.14–3.48]; p = 0.014) were found to be associated with decreased and increased risk of cervicitis respectively. Conclusions TLR4 and TLR9 polymorphisms, as well as haplotypes were shown to modulate the cervicitis risk.

No abstract

The Author Contributions section in this Article is incorrect. "All the authors have contributed significantly, read the manuscript, and agrees to its submission to Gynecologic Oncology. In this study N.P. and A.C. have performed experimental work, analysis and interpretation of data, preparation and drafting of manuscript. N.R., P.P. and A.D. have supervised the study as clinical investigators and critically reviewed the study proposal. R.K., Y.C. and R.S.K. have contributed in sample/data collection and analysis, and reviewed the manuscript critically. The task of conceptualization, funding acquisition, project administration, supervision, validation, review and editing was performed by N.J. " should read: "All the authors have contributed significantly, read the manuscript, and agrees to its submission to Scientific Reports. In this study N.P. and A.C. have performed experimental work, analysis and interpretation of data, preparation and drafting of manuscript. N.R., P.P. and A.D. have supervised the study as clinical investigators and critically reviewed the study proposal. R.K., Y.C. and R.S.K. have contributed in sample/data collection and analysis, and reviewed the manuscript critically. The task of conceptualization, funding acquisition, project administration, supervision, validation, review and editing was performed by N.J. "